IL13 and pulmonary arterial hypertension: In this study, we evaluated the combined effects of PAH toxicity and IL-13-induced asthmatic inflammation in primary HBEC differentiated at the air-liquid interface to evaluate whether the IL-13 phenotype has altered susceptibility to BAP toxicity compared to cells with the normal phenotype.